Aberdeen Group plc grew its position in Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 3.5% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,166,202 shares of the real estate investment trust's stock after purchasing an additional 38,952 shares during the period. Aberdeen Group plc owned about 0.40% of Omega Healthcare Investors worth $42,193,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. Farther Finance Advisors LLC raised its holdings in shares of Omega Healthcare Investors by 7.1% during the second quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust's stock worth $153,000 after acquiring an additional 279 shares during the period. United Services Automobile Association grew its position in Omega Healthcare Investors by 1.8% in the first quarter. United Services Automobile Association now owns 16,598 shares of the real estate investment trust's stock valued at $632,000 after purchasing an additional 291 shares in the last quarter. Optimum Investment Advisors grew its position in Omega Healthcare Investors by 8.9% in the first quarter. Optimum Investment Advisors now owns 3,666 shares of the real estate investment trust's stock valued at $140,000 after purchasing an additional 300 shares in the last quarter. CreativeOne Wealth LLC grew its position in Omega Healthcare Investors by 3.4% in the first quarter. CreativeOne Wealth LLC now owns 9,487 shares of the real estate investment trust's stock valued at $361,000 after purchasing an additional 310 shares in the last quarter. Finally, Values First Advisors Inc. grew its position in Omega Healthcare Investors by 1.6% in the first quarter. Values First Advisors Inc. now owns 19,692 shares of the real estate investment trust's stock valued at $750,000 after purchasing an additional 314 shares in the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research analysts recently weighed in on OHI shares. Mizuho raised their target price on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the company a "neutral" rating in a research report on Thursday, September 11th. Raymond James Financial reaffirmed an "outperform" rating on shares of Omega Healthcare Investors in a research report on Tuesday, September 2nd. Truist Financial raised their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research report on Wednesday, September 3rd. Royal Bank Of Canada raised their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Finally, Wells Fargo & Company raised their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. Seven research analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $44.44.
Get Our Latest Research Report on OHI
Omega Healthcare Investors Stock Performance
Shares of OHI opened at $39.83 on Monday. The firm has a 50-day moving average of $41.57 and a 200-day moving average of $38.82. Omega Healthcare Investors, Inc. has a one year low of $35.04 and a one year high of $44.42. The company has a market cap of $11.75 billion, a PE ratio of 24.59, a price-to-earnings-growth ratio of 1.86 and a beta of 0.70. The company has a debt-to-equity ratio of 0.96, a current ratio of 7.10 and a quick ratio of 7.10.
Omega Healthcare Investors (NYSE:OHI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, beating analysts' consensus estimates of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The company had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same quarter last year, the firm posted $0.71 EPS. The company's quarterly revenue was up 11.8% on a year-over-year basis. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. As a group, equities analysts forecast that Omega Healthcare Investors, Inc. will post 2.86 earnings per share for the current year.
Omega Healthcare Investors Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Monday, August 4th were given a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.7%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio (DPR) is 165.43%.
Insider Activity at Omega Healthcare Investors
In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of Omega Healthcare Investors stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the sale, the director owned 18,654 shares of the company's stock, valued at approximately $749,144.64. The trade was a 11.82% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company's stock.
Omega Healthcare Investors Company Profile
(
Free Report)
Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Omega Healthcare Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Omega Healthcare Investors wasn't on the list.
While Omega Healthcare Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.